+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Ursodeoxycholate attenuates enhanced expression levels in gallbladder group II phospholipase A-2 and reduces biliary protein and viscosity in patients with multiple cholesterol stones



Ursodeoxycholate attenuates enhanced expression levels in gallbladder group II phospholipase A-2 and reduces biliary protein and viscosity in patients with multiple cholesterol stones



Gastroenterology 112(4 SUPPL ): A1297




(PDF emailed within 1 workday: $29.90)

Accession: 034144754

Download citation: RISBibTeXText


Related references

The increase in group II phospholipase, A-2 enzyme protein and its association with higher protein and viscosity of gallbladder bile with multiple cholesterol stones. Gastroenterology 110(4 SUPPL ): A1325, 1996

Increased biliary group II phospholipase A-2 and altered gallbladder bile in patients with multiple cholesterol stones. Gastroenterology. 112(6): 2036-2047, 1997

Effects of long-term ursodeoxycholate administration on expression levels of secretory low molecular weight phospholipase A2 and mucin genes in patients with multiple cholesterol stones. Gastroenterology 114(4 PART 2): A1267, April 15, 1998

Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones. Hepatology 28(2): 302-313, 1998

Total biliary protein, mucus glycoproteins, cyclic-AMP, and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls. Scandinavian Journal of Gastroenterology 26(7): 771-778, 1991

Effect of biliary phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones. Gastroenterology 104(4 SUPPL ): A924, 1993

Mucin and phospholipids determine viscosity of gallbladder bile in patients with cholesterol and mixed stones. Gastroenterology 118(4 Suppl 2 Part 1): A8, 2000

Chemopreventive role of ursodeoxycholate in animal colon cancer model Suppressive effects on arachidonate metabolism through the modulation of enhanced group II phospholipase A-2 expression in colonic tissue. Gastroenterology 112(4 SUPPL ): A582, 1997

Does deoxycholic acid, gallbladder function, biliary protein and glycoprotein contribute to cholesterol nucleation in patients with solitary or multiple gallstones?. European Journal of Clinical Investigation 27(SUPPL 1): A10, 1997

Ursodeoxycholic acid reduces protein levels and their nucleation promoting activity in gallbladder bile of cholesterol stone patients. Hepatology 22(4 PART 2): 504A, 1995

Sedimentation of biliary sludge: effect on composition of gallbladder bile from patients with cholesterol, mixed, or pigment stones. Scandinavian Journal of Gastroenterology 31(3): 273-278, 1996

Dissolving of cholesterol gallstones. Differences in the treatment of gallbladder and biliary stones. Zfa. Zeitschrift für Allgemeinmedizin 54(2): 70-74, 1978

Levels of serum and biliary lipids and their composition in patients with pure cholesterol and mixed gall stones. Hiroshima Journal of Medical Sciences 31(1): 11-20, 1982

Crystallization of cholesterol Effect on the relation of cholesterol in vesicles and micelles in gallbladder bile of patients with cholesterol stones. Gastroenterology 108(4 SUPPL ): A1093, 1995

Multiple cholesterol stones can form by deposition of cholesterol crystals over a pigment nucleus Cholesterol deposition sometimes begins with the Rokitansky-Aschoff sinuses of the gallbladder wall. Gastroenterology 108(4 SUPPL ): A410, 1995